Two Way Crossover Closed Loop Study Insulin vs Insulin and Pramlintide
NCT: NCT06422325 · COMPLETED
Brief Summary
The purpose of this study is to test how well a new investigational closed loop system manages your blood sugar with the ability to deliver insulin and pramlintide. Pramlintide is a drug that is used with mealtime insulin to control blood sugar in people who have diabetes. It works by slowing down the movement of food through the stomach which prevents blood sugar from rising too high after a meal. The closed loop system will receive glucose values from the Dexcom G6 continuous glucose monitoring (CGM) and automatically send commands to one Omnipod for insulin and one Omnipod for pramlintide delivery.
Frequently Asked Questions
What is Two Way Crossover Closed Loop Study Insulin vs Insulin and Pramlintide?
Two Way Crossover Closed Loop Study Insulin vs Insulin and Pramlintide is a clinical trial registered under NCT06422325. Current status: COMPLETED.
What is the status of NCT06422325?
The current status of NCT06422325 (Two Way Crossover Closed Loop Study Insulin vs Insulin and Pramlintide) is: COMPLETED.
When did Two Way Crossover Closed Loop Study Insulin vs Insulin and Pramlintide start?
Two Way Crossover Closed Loop Study Insulin vs Insulin and Pramlintide started on 2024-07-12.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.